-
Product Insights
Respiratory Disease Tests – Chembio Diagnostics, Inc – DPP
GlobalData, the industry analysis specialist, has released its latest report: Respiratory Disease Tests - Chembio Diagnostics, Inc - DPP. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by...
-
Product Insights
COVID-19 Tests – Chembio Diagnostics, Inc – DPP
GlobalData, the industry analysis specialist, has released its latest report: COVID-19 Tests - Chembio Diagnostics, Inc - DPP. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by the...
-
Company Profile
Chembio Diagnostic Inc – Company Profile
Chembio Diagnostic Inc (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases including COVID-19, sexually transmitted disease, and fever and tropical disease. The company offers products to prevent the spread of infectious diseases with solutions includes Dual Path Platform (DPP). Its DPP technology is used to treat infectious diseases such as HIV, Ebola, syphilis, Zika, malaria and febrile illness. Chembio also offers veterinary diagnostics. The company offers products to medical laboratories and hospitals,...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – DPP-017
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry DPP-017 Drug Details DPP-017 is under development for the treatment of psoriasis. It is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (metformin + dapagliflozin + sitagliptin)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry (metformin + dapagliflozin + sitagliptin) Drug Details The fixed dose combination of metformin, dapagliflozin...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (metformin + sitagliptin hydrochloride)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry (metformin + sitagliptin hydrochloride) Drug Details GLH-1SM is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – REC-02
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry REC-02 Drug Details REC-02 is under development for the treatment of congestive heart failure...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – dutogliptin tartrate
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry dutogliptin tartrate Drug Details Dutogliptin tartrate (REC-01) is under development for the treatment of...
-
Product Insights
Immunochemistry Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Spot test kits intended generally for rapid diagnosis, with immediate results, through immuno assays. Some of the tests carried out using immunochemistry rapid test include rabies virus test, allergenic food proteins, and enteric infection. The immunochemistry rapid tests and POC pipeline market research report provides comprehensive information about the immunochemistry rapid tests and POC pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Bacteriology Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Bacteriology Rapid Tests & POC comprises rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for Chlamydia, H. pylori, Streptococci, and Syphilis. The Bacteriology Rapid Tests & POC pipeline market research report provides comprehensive information about the Bacteriology Rapid Tests & POC pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.